(Q61975444)
Statements
A Multicenter Randomized, Double-blind, Placebo Controlled ,Parallel Group ,Phase II Study to Access the Efficacy and Safety of SP2086 in Combination Therapy With Metformin in Patients With Type 2 Diabetes Patients (English)
0 references
March 2012
0 references
August 2012
0 references
120
0 references
20 year
0 references
70 year
0 references